Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 12, No 6 (2016) THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 Abstract  PDF (Eng)  PDF (Eng)  similar documents
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov
"... treatment stages in patients at high and very high cardiovascular risk during 2011-2015. Material ..."
 
Vol 10, No 6 (2014) THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY Abstract  similar documents
D. A. Andreev
"... , relation of platelet reactivity with the risk of adverse events, as well as factors that contribute to high ..."
 
Vol 11, No 2 (2015) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? Abstract  similar documents
S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov
"... , high risk of cardiovascular disease, dyslipidemia. Ration Pharmacother Cardiol 2015;11(2):167-169 ..."
 
Vol 12, No 3 (2016) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? Abstract  PDF (Eng)  similar documents
S. N. Bel'diev
"... guidelines for management of patients with high cardiovascular risk; 2) common perception that isolated ..."
 
Vol 8, No 1 (2012) THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE Abstract  similar documents
V. V. Yakusevich, A. Yu. Malygin, S. V. Lychenko, A. S. Petrochenko, A. V. Kabanov
"... . The efficacy of high-dose simvastatin (40 mg/day) therapy initiated in acute stage of ischemic stroke ..."
 
Vol 9, No 4 (2013) REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy
"... from May, 1st till December, 31st, 2011 were divided into 3 groups: a control group (82 patients who ..."
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
"... (p<0.001). There was demonstrated a high adherence to UDCA therapy. Conclusion. Combined therapy ..."
 
Vol 2, No 4 (2006) FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS Abstract  similar documents
Yu. M. Lopatin
"... enzyme inhibitor (iACE) ramipril improves the prognosis in high risk cardio-vascular patients ..."
 
Vol 13, No 1 (2017) FROM PERSONALIZED TO PRECISION MEDICINE Abstract  similar documents
K. V. Raskina, E. Y. Martynova, A. V. Perfilyev, D. A. Sychev, G. N. Shuev, I. R. Fatkhutdinov, S. V. Musienko, D. A. Nikogosov, I. O. Zhegulina, L. G. Bavykina, Y. E. Poteshkin
"... The need to maintain a high quality of life against a backdrop of its inevitably increasing ..."
 
Vol 13, No 4 (2017) HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE? Abstract  similar documents
I. S. Yavelov, M. V. Zhatkina, O. M. Drapkina, A. Yu. Gorshkov, N. O. Myasnikova
"... statins in high doses before percutaneous coronary interventions (PCI) are presented in the review ..."
 
Vol 13, No 1 (2017) SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION Abstract  similar documents
S. N. Bel'diev
"... Russian physicians often afraid to use statins in patients with high cardiovascular risk ..."
 
Vol 10, No 1 (2014) MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) Abstract  PDF (Eng)  similar documents
A. M. Kalinina
"... 1 – n=2975, the group 2 – n=2705. Active correction of IHD RF (high blood pressure ..."
 
Vol 7, No 3 (2011) THE NEWS FROM RECENT CONGRESS OF AMERICAN COLLEGE OF CARDIOLOGY (NEW ORLEANS, APRIL 2-5, 2011)  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Y. Drozdova
"... Рациональная Фармакотерапия в Кардиологии 2011;7(3) 391 ФОРУМЫ 2-5 Апреля 2011 г. в Новом Орлеане ..."
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
"... in patients with cardiovascular diseases (CVD) and high risk of cardiovascular events (CVE) with indications ..."
 
Vol 2, No 2 (2006) METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS Abstract  similar documents
N. V. Perova, I. N. Ozerova, V. A. Metelskaya
"... thoroughly; proteins regulating its transportation are described. Important place takes the role of high ..."
 
Vol 7, No 3 (2011) MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya, T. G. Kheliya, N. P. Kutishenko
"... antiplatelet therapy of ischemic heart disease patients with high risk of thrombotic events: data from evidence ..."
 
Vol 13, No 5 (2017) IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? Abstract  similar documents
A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova
"... at high risk is critical in reducing morbidity and mortality from cardiovascular diseases. Aim. To assess ..."
 
Vol 7, No 5 (2011) AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION Abstract  similar documents
A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva
"... - in the control one. A number of angina pectoris daily episodes decreased from 2.4±0.3 to 1.8±0.2 in the main ..."
 
Vol 7, No 5 (2011) HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY  similar documents
G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio
"... антиагрегантного, но и других биологических эффектов. Цель. Сравнить влияние поддерживающего лечения высокой и ..."
 
Vol 12, No 6 (2016) NEW DATA OF EXTENSIVE RESEARCH PROGRAM AND THE RESULTS OF STUDIES IN REAL CLINICAL PRACTICE FROM DIFFERENT COUNTRIES REAFFIRMED THE HIGH EFFICACY AND A FAVORABLE SAFETY PROFILE OF RIVAROXABAN (XARELTO®) FROM THE BAYER COMPANY PRESS RELEASE OF THE BAYER COMPANY Abstract  similar documents
article editorial
"... клинической практики из разных стран вновь подтвердили высокую эффективность и благоприятный профиль ..."
 
Vol 7, No 4 (2011) USE OF FIXED COMBINATIONS OF RAMIPRIL AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH OR VERY HIGH CARDIOVASCULAR RISK (OPTIMIST 2 STUDY): RESULTS OF THE NONCOMPARATIVE STUDY Abstract  similar documents
I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, A. V. Rudakov, T. S. Zhupanova
"... and hydrochlorothiazide in patients with arterial hypertension (HT) 2-3 degree and high or very high cardiovascular risk ..."
 
Vol 12, No 4 (2016) New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) Abstract  similar documents
Article Editorial
"... ПОДТВЕРДИЛИ ВЫСОКУЮ ЭФФЕКТИВНОСТЬ И БЛАГОПРИЯТНЫЙ ПРОФИЛЬ БЕЗОПАСНОСТИ ПРЕПАРАТА КСАРЕЛТО® У ПАЦИЕНТОВ С ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES Abstract  similar documents
A. N. Meshkov
"... therapy in high doses is discussed in patients with IHD and dyslipidemia. Atorvastatin in high doses ..."
 
Vol 8, No 2 (2012) UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev
"... infarction in two towns of Lyubertsy and Podolsk. 28 of 71 patients (39%) took the DAT (from some days to 6 ..."
 
Vol 8, No 4 (2012) RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS  similar documents
S. R. Willoughby, S. Rajendran, W. P. Chan, N. Procter, S. Leslie, E. A. Liberts, T. Heresztyn, Y. Y. Chirkov, J. D. Horowitz
"... высоким сердечно-сосудистым риском с критериями включения, аналогичными исследованию HOPE (Heart Outcomes ..."
 
Vol 11, No 4 (2015) SLEEP DURATION: MODERN VIEW OF THE PROBLEM FROM THE STANDPOINT OF A CARDIOLOGIST Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
"... , atherosclerosis and other diseases with high mortality both in Russia and worldwide. This article presents ..."
 
Vol 6, No 4 (2010) RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE Abstract  similar documents
M. V. Ezhov
"... The results of the recently completed clinical studies on the efficacy of atorvastatin in high ..."
 
Vol 3, No 3 (2007) REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS Abstract  similar documents
M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova
"... studies. In high risk patients monotherapy with Enam (enalapril, Dr. Reddy’s) decreases blood pressure ..."
 
Vol 11, No 4 (2015) INNOVATIVE TECHNOLOGIES IN CARDIOLOGY: FROM SURPRISE TO HABIT OR FORGETFULNESS Abstract  similar documents
S. R. Gilyarevskiy, M. V. Golshmid, I. M. Kuz'mina
"... . Examples reflecting the initiation of interest in the new technology of treatment, the transition from ..."
 
Vol 8, No 1 (2012) EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK Abstract  similar documents
I. M. Sokolov, N. A. Zheleznyakova
"... The high prevalence of arterial hypertension in association with high and very high cardiovascular ..."
 
Vol 12, No 2 (2016) THE ASSOCIATION OF DEPRESSION WITH C-REACTIVE PROTEIN (THE DATA OF ESSE-RF EPIDEMIOLOGICAL STUDY) Abstract  similar documents
S. E. Evstifeeva, S. A. Shalnova, A. D. Deev, V. A. Metelskaya, G. V. Artamonova, O. A. Belova, J. V. Zhernakova, A. Yu. Efanov, A. O. Konradi, N. V. Kulakova, O. P. Rotar, G. V. Tolparov, I. A. Trubacheva, A. A. Shabunova, S. A. Boytsov
"... Aim. To study the association of depression with a high-sensitivity C-reactive protein (hsCRP ..."
 
Vol 10, No 3 (2014) THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) Abstract  similar documents
M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev
"... endpoint – total mortality. Stage 2: the continuation of register "LIS-1" (2011-2012). Results.1133 ..."
 
Vol 10, No 5 (2014) RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME Abstract  similar documents
N. V. Perova, V. A. Metelskaya
"... Рекомендациях по лечению ДЛП (2011), подго- товленных специалистами двух Европейских научных обществ ..."
 
Vol 8, No 5 (2012) HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... examined. The control group consisted of 125 women without rheumatic diseases. Aside from clinical symptoms ..."
 
Vol 12, No 1 (2016) Pharmacotherapy of pulmonary hypertension (according to the 2015 ESC/EAS Guidelines for the diagnosis and treatment of pulmonary hypertension) Abstract  PDF (Eng)  similar documents
E. L. Trisvetova, S. V. Gubkin
"... рекомендациях по диагностике и лечению легочной гипертензии (2015 ESC/ERS Guidelines for the diagnosis ..."
 
Vol 13, No 4 (2017) GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Abstract  similar documents
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava
"... predictors of its effectiveness in patients with very high cardiovascular risk. Material and methods. 58 ..."
 
Vol 13, No 2 (2017) COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH Abstract  similar documents
O. M. Drapkina
"... /amlodipine. Doctors noted high satisfaction with the therapy. According to safety assessment the average ..."
 
Vol 12, No 4 (2016) High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice Abstract  similar documents
N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova
"... Aim. To study the prevalence of high residual platelet reactivity (HRPR) during the dual ..."
 
Vol 11, No 6 (2015) Analysis of the problem of low adherence of patients to attendance at outpatient clinics and cardiorehabilitation programs according to the data from published studies Abstract  similar documents
Yu. V. Semenova, N. P. Kutishenko, S. Yu. Martsevich
"... of relevant literature data. Pubmed and Cyberlenica articles and abstracts, published in 1966-2015, concerning ..."
 
Vol 12, No 4 (2016) Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk Abstract  similar documents
O. M. Drapkina, O. N. Korneeva
"... for a number of cardiovascular diseases (CVD), is considered. The high prevalence of cardiovascular risk ..."
 
Vol 8, No 2 (2012) SYNCOPE IN NON-MASSIVE PULMONARY EMBOLISM AS A PREDICTOR OF HIGH-RISK MORTALITY Abstract  similar documents
E. A. Kurakina, D. V. Duplyakov, S. M. Khokhlunov, G. S. Kozupitsa
"... %) patients had a high risk of death according to the ESC criteria, and 51 (80%) — an intermediate risk. PE ..."
 
Vol 6, No 4 (2010) EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE Abstract  similar documents
M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya
"... in hypertensive men with high cardiovascular risk. Materials and methods. Hypertensive men (n=21) with high ..."
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... patients with STEMI aged 32 to 65 years. In the first 24-96 hours from the disease onset the patients were ..."
 
Vol 4, No 4 (2008) INCREASED PLASMA LEVEL OF D-DIMER AS A MARKER OF HIGH ARTERIAL THROMBOSIS RISK Abstract  similar documents
N. V. Furman, N. F. Puchinjan, O. M. Ansimova, P. J. Dovgalevsky
"... as laboratory indicators. At the same time new markers of high cardiovascular risk are under development. D ..."
 
Vol 5, No 6 (2009) EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) Abstract  similar documents
I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko
"... ; with combination of HT and ischemic heart disease; with ischemic heart disease and high normal blood pressure (BP ..."
 
Vol 15, No 1 (2019) Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City Abstract  similar documents
A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich
"... of OAC prescription from 30% in 2015 to 38.4% in 2017. Conclusion. Only 32% of patients with AF and high ..."
 
Vol 12, No 3 (2016) EFFECT OF OBSTRUCTIVE SLEEP APNEA SYNDROME ON ARTERIAL STIFFNESS IN PATIENTS AT HIGH CARDIOVASCULAR RISK Abstract  PDF (Eng)  similar documents
V. E. Oleynikov, N. V. Burko, L. I. Salyamova, K. A. Ziboreva
"... толщину комплекса интима-медиа (ТКИМ). Результаты. Больные с ИАГ >30 эпизодов/час имели более высокие ..."
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... Достижение целевого уровня липидов у больных высокого сердечно-сосудистого риска: имеет ли значение ..."
 
Vol 4, No 5 (2008) COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... ,0 mmol/l and high cardiovascular risk were involved into the study. During 5 weeks before study including ..."
 
Vol 8, No 6 (2012) THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... and methods. Women with high activity of RA (n=130) were examined. Women without rheumatic diseases (n=25 ..."
 
Vol 4, No 5 (2008) EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... duration was from 1 to 22 years (8,3 years in average). 47 patients completed study, 3 patients drop out ..."
 
Vol 13, No 1 (2017) EVALUATION OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BEFORE REFERENCE EVENT AND BEFORE DISCHARGE FROM THE HOSPITAL: REGISTER DATA (KHABAROVSK CITY). PART 2 Abstract  similar documents
L. N. Malay, S. Yu. Martsevich, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, N. B. Garayeva, A. Ya. Letskin
"... in Khabarovsk Regional Vascular Center was characterized by a high rate of primary PCI, DATT, enoxaparin ..."
 
Vol 12, No 2 (2016) ESTIMATION OF HIGHLY SENSITIVE TROPONIN TESTS IN THE DIAGNOSIS OF ACUTE CORONARY SYNDROME Abstract  similar documents
L. V. Kremneva, S. N. Suplotov, S. V. Shalaev
"... in 2012. Study results of 2011-2015 years are presented as the basis for the development of a one-hour MI ..."
 
Vol 6, No 1 (2010) COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, A. A. Serazhim, V. P. Voronina, M. A. Maksimova, L. Yu. Drozdova, A. V. Zakharova
"... with arterial hypertension (HT) of 1-2 degree and high cardiovascular risk, and to evaluate target blood ..."
 
Vol 4, No 2 (2008) FROM THE SHORT ACTING NIFEDIPINE TO AMLODIPINE AND FIXED COMBINATIONS. HIGHLIGHTS THE PROBLEM FROM THE CURRENT GUIDELINES POINT OF VIEW Abstract  similar documents
L. I. Katelnitskaya, L. A. Haisheva
"... of current recommendations. Results of some large clinical trials confirm high antihypertensive efficacy ..."
 
Vol 10, No 1 (2014) SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE) Abstract  similar documents
R. Eschalier, J.J.V. McMurray, K. Swedberg, D.J. Veldhuisen van, H. Krum, S.J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt
"... and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function. Analyses ..."
 
Vol 7, No 2 (2011) REPORT ON SCIENTIFIC AND EDUCATIONAL FORUM “CARDIOLOGY 2011”  similar documents
G. Ya. Maslennikova
"... Рациональная Фармакотерапия в Кардиологии 2011;7(2) 267 Сердечно-сосудистые заболевания (ССЗ ..."
 
Vol 13, No 2 (2017) ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC Abstract  PDF (Eng)  similar documents
E. V. Stepina, M. M. Loukianov, M. A. Bichurina, E. N. Belova, E. V. Kudryashov, Ju. V. Uzkov, S. A. Boytsov
"... %) in high-risk patients after discharge from hospital. ..."
 
Vol 8, No 1 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... antihypertensive therapy. Data from clinical trials. Part 1. V.V. Popov1*, N.A. Bulanov2, G.G. Ivanov2 1 Research ..."
 
Vol 8, No 2 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... исследования. РФК 2012;8(2):226-232 Current target of antihypertensive therapy. Data from clinical trials ..."
 
Vol 9, No 4 (2013) ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT Abstract  similar documents
S. Yu. Martsevich
"... -analyzes comparing ACEi and ARB effects on the life prognosis in patients of the high cardiovascular risk ..."
 
Vol 7, No 5 (2011): ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ ЛЕКАРСТВЕННОЙ ТЕРАПИИ ПРИ ПЕРВИЧНОЙ И ВТОРИЧНОЙ ПРОФИЛАКТИКЕ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ. РЕКОМЕНДАЦИИ ВНОК, 2011 Abstract  similar documents
, , , , , , , ,
"... 2 Рациональная Фармакотерапия в Кардиологии 2011; Приложение к №5 ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ ..."
 
Vol 11, No 5 (2015) Three-year dynamics and unsolved problems of lipid-lowering therapy Abstract  similar documents
V. A. Sergeeva
"... of patients at a high cardiovascular risk of atherosclerosis problems and the dynamics of these parameters ..."
 
Vol 4, No 1 (2008) WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL Abstract  similar documents
M. N. Mamedov, M. B. Stroeva
"... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..."
 
Vol 6, No 6 (2010) COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina
"... acetylsalicylic acid (ASA) in patients with high cardiovascular risk. Material and мethods. Patients (n=30 ..."
 
Vol 7, No 5 (2011) HEREDITARY INTRAVENTRICULAR CONDUCTION DISORDERS IN THE FAMILY FROM KRASNOYARSK Abstract  similar documents
A. A. Chernova, S. Yu. Nikulina, S. S. Tret'yakova, T. I. Ul'yanova
"... Pedigree of the family from Krasnoyarsk city with hereditary disorders of intracardiac conduction ..."
 
Vol 11, No 1 (2015) III INTERNATIONAL CONGRESS “ARTERIAL HYPERTENSION – FROM KOROTKOV TO THIS DATE” 21-23 MAY 2015, ST. PETERSBURG Abstract  similar documents
"... Рациональная Фармакотерапия в Кардиологии 2015;11(1) 109 III МЕЖДУНАРОДНЫЙ КОНГРЕСС «АРТЕРИАЛЬНАЯ ..."
 
Vol 11, No 2 (2015) III INTERNATIONAL CONGRESS “ARTERIAL HYPERTENSION – FROM KOROTKOV TO THIS DATE” 21-23 MAY 2015, ST. PETERSBURG Abstract  similar documents
"... Рациональная Фармакотерапия в Кардиологии 2015;11(2) 229 III МЕЖДУНАРОДНЫЙ КОНГРЕСС «АРТЕРИАЛЬНАЯ ..."
 
Vol 4, No 2 (2008) NEWS FROM THE CONGRESS OF AMERICAN COLLEGE OF CARDIOLOGY Abstract  similar documents
S. Y. Martsevich
"... в предупреждении сердечно-сосудистых осложнений у больных высокого риска (74%имелиИБС, 21% - пе ..."
 
Vol 8, No 4 (2012) COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»  similar documents
D. V. Nebieridze
"... ЛЕЧЕНИЯ БОЛЬНЫХ С ВЫСОКИМ СЕРДЕЧНО-СОСУДИСТЫМ РИСКОМ» (RAMIPRIL SENSITIZES PLATELETS TO NITRIC OXIDE ..."
 
Vol 11, No 1 (2015) ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE Abstract  similar documents
M. V. Solodun, S. S. Yakushin
"... Рациональная Фармакотерапия в Кардиологии 2015;11(1) 31 В настоящее время лечение ишемической ..."
 
Vol 2, No 3 (2006) COMPARATIVE RESEARCH OF ENALAPRIL AND ATENOLOL ANTIHYPERTENSIVE EFFICACY IN HIGH RISK PATIENTS Abstract  similar documents
O. M. Moiseeva, S. V. Villevalde, I. V. Emelyanov, T. G. Ivanova
"... is very important in prevention of cardiovascular complications especially in high risk patients. ..."
 
Vol 8, No 1 (2012) BRIEFING NOTE ABOUT ACTIVITY OF EDITORIAL BOARD OF “RATIONAL PHARMACOTHERAPY IN CARDIOLOGY” IN 2011 Abstract  similar documents
G. Ya. Maslennikova
"... Copernicus и Ulrich’ Periodicals Directory. Статистика. За период с января по декабрь 2011 г. в редакцию ..."
 
Vol 7, No 3 (2011) NATIONAL AWARD IN CARDIOLOGY «PURPLE HEART». PRESS-RELEASE 19.05.2011  similar documents
"... 396 Рациональная Фармакотерапия в Кардиологии 2011;7(3) 19 мая в Москве в Государственном музее А ..."
 
Vol 13, No 4 (2017) OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT Abstract  similar documents
I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova
"... , total cholesterol, triglycerides, high density lipoprotein cholesterol (HDL cholesterol), low density ..."
 
Vol 11, No 3 (2015) ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta
"... Aim. To study the level of total cholesterol in patients at high and very high cardiovascular risk ..."
 
Vol 14, No 6 (2018) Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan
"... Aim. To study adherence to treatment with generic statins prescribed to patients with high and very ..."
 
Vol 8, No 4 (2012) HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
V. P. Lupanov
"... напряжения В настоящее время доказана высокая эффективность и безопасность бета-адреноблокаторов (БАБ) при ..."
 
Vol 7, No 6 (2011) CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM Abstract  similar documents
Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov
"... Infarction Caused by Coronary Embolism from Infective En- docarditis. The Journal of Emergency Medicine 2011 ..."
 
Vol 12, No 1 (2016) The main factors affecting the long-term outcomes in patients after acute cerebrovascular disorder: results of the LIS-2 study Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, A. V. Suvorov, A. V. Zagrebelnyy, M. L. Ginzburg, A. D. Deev
"... or transient ischemic attack in the period from 01.01.2009 to 31.12.2011, admitted to Lyubertsy district ..."
 
Vol 7, No 1 (2011) THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY Abstract  similar documents
S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich
"... Рациональная Фармакотерапия в Кардиологии 2011;7(1) 37 Сведения об авторах: Марцевич Сергей ..."
 
Vol 13, No 4 (2017) CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA Abstract  similar documents
S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, Yu. V. Lukina, M. M. Loukianov, A. N. Vorobyev, A. N. Kozminsky
"... center in Moscow from 2011 to 2015 (n=1531) were analyzed as well as data of the RECVASA registry ..."
 
Vol 7, No 1 (2011) SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina
"... 70 Рациональная Фармакотерапия в Кардиологии 2011;7(1) Истина в науке. Не позволяйте фактам ..."
 
Vol 15, No 2 (2019) Cardiovascular medicine prices as an indicator of access to medicines and their rational use Abstract  similar documents
C M. Razzakova, L. E. Ziganshina
"... from 208 to 281 05 rubles. Conclusion. Over the five years from 2011 to 2015, there was a general ..."
 
Vol 11, No 1 (2015) CHARACTERISTICS OF PATIENTS WITH CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK, INCLUDED INTO THE LIS-2 REGISTER (LYUBERTSY STUDY OF MORTALITY IN PATIENTS AFTER STROKE) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, A. Yu. Suvorov, M. L. Ginzburg, A. D. Deev, S. A. Boytsov, A. V. Akimova, E. V. Daniels, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov, V. P. Smirnov, A. V. Fokina
"... to the Lyubertsy district hospital №2 with stroke for the period from 01.2009 to 12.2011 were included ..."
 
Vol 9, No 2 (2013) TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... According to the data from PROGNOZ IBS register drugs with proven efficacy in secondary prevention ..."
 
Vol 5, No 3 (2009) ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT Abstract  similar documents
V. N. Isakova, O. G. Garbuzova, E. V. Klinkova, E. V. Bandurko
"... with moderate/high cardiovascular risk receiving lisinopril and simvastatin. Material and methods. 20 patients ..."
 
Vol 14, No 6 (2018) Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk Abstract  PDF (Eng)  similar documents
O. Yu. Korennova, S. P. Podolnaya, E. P. Prihodko, E. A. Turusheva, S. N. Starinskaya, I. A. Вratishko, I. V. Druk
"... of amlodipine and ramipril in hypertensive patients with very high cardiovascular risk. Material and methods ..."
 
Vol 9, No 5 (2013) TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... in hospital and after hospital discharge. Material and methods. Data on 550 patients (from PROGNOZ IBS ..."
 
Vol 15, No 1 (2019) Factors Associated with Cause-Specific Death in Russia. Data from Longitudinal Prospective Study 1977-2001 Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. V. Kapustina, A. D. Deev, Yu. A. Balanova
"... ,924 – in women (for 20 years). Results. Men died more often from all the examined causes except for stroke, what ..."
 
Vol 11, No 5 (2015) News of the European Society of Cardiology Congress (London, 28 August - 2 September 2015): old drugs may be better than the new ones Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko
"... News of the European Society of Cardiology Congress (London, 2015) is presented. The results ..."
 
Vol 15, No 1 (2019) The Trends of Cardiovascular and Cancer Mortality in Russian Men and Women from 2000 to 2016 years Abstract  similar documents
S. A. Shalnova, O. M. Drapkina
"... Aim. To compare trends from CVD and cancer mortality in the Russian Federation from 2000 to 2016 ..."
 
Vol 11, No 3 (2015) EVALUATION OF THE REGULARITY OF ANTIHYPERTENSIVE DRUGS USAGE AS A COMPONENT OF TREATMENT ADHERENCE IN OUTPATIENTS OF A SPECIALIZED CARDIOLOGY CENTER Abstract  PDF (Eng)  similar documents
A. V. Kontsevaya, T. S. Romanenko, V. A. Vygodin, S.B B. Fitilev
"... High adherence to blood pressure (BP) medical correction determines clinical and socioeconomic ..."
 
Vol 13, No 2 (2017) TREATMENT CHARACTERISTICS OF ACUTE CORONARY SYNDROME IN ELDERLY PATIENTS: PRACTICE OF N.I. PIROGOV CITY CLINICAL HOSPITAL №1 Abstract  similar documents
M. Yu. Gilyarov, M. O. Zheltoukhova, E. V. Konstantinova, M. D. Muksinova, L. S. Muradova, A. P. Nesterov, A. E. Udovichenko
"... % of cases; DAT was performed significantly more often in 2015 than in 2014. Conclusion. There are a high ..."
 
Vol 12, No 1 (2016) Report on activity of editorial board of “Rational Pharmacotherapy in Cardiology” in 2015 Abstract  similar documents
M. I. Smirnova
"... высокого уровня публи- куемых результатов диагностических и прогностических исследований в 2015 г. вышла ..."
 
Vol 5, No 3 (2009) EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS Abstract  similar documents
A. R. Kiselev, V. I. Gridnev, A. S. Karavaev, O. M. Posnenkova, V. A. Shvarts, V. I. Ponomarenko, M. D. Prokhorov, B. P. Bezruchko
"... and microcirculatory vessels in patients with arterial hypertension (HT) of 1-2 degrees and high body mass/obesity ..."
 
Vol 9, No 5 (2013) THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION Abstract  similar documents
R. N. Adzhiev, M. S. Safarova, M. V. Ezhov
"... Review of large of trials that prove the positive impact of high-dose lipid-lowering therapy ..."
 
Vol 7, No 4 (2011): ДИАГНОСТИКА И ЛЕЧЕНИЕ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ. РЕКОМЕНДАЦИИ ВНОК И ВНОА, 2011 Г. Abstract  similar documents
"... Рациональная Фармакотерапия в Кардиологии 2011; Приложение к №4 5 Диагностика и лечение ..."
 
Vol 3, No 3 (2007) MAXIMAL REDUCTION OF CARDIOVASCULAR COMPLICATIONS RISK – THE MAIN TASK OF MODERN THERAPY FOR HIGH RISK PATIENTS. RANDOMIZED STUDY ON COMPREHENSIVE CONTROL ON ARTERIAL HYPERTENSION AND DYSLIPIDAEMIA Abstract  similar documents
N. P. Kutishenko, V. V. Yakusevich, A. A. Seragzim, A. D. Deev, S. Y. Martsevich
"... Maximal reduction of cardiovascular complications risk – the main task of modern therapy for high ..."
 
Vol 5, No 1 (2009) CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. A. Anichkov, A. A. Platonova
"... Aim. To estimate heart rate variability (HRV) from 5-min and 24-h electrocardiogram (ECG ..."
 
1 - 100 of 1433 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)